Matches in Nanopublications for { ?s ?p "[We describe the development of the first ELISA for myostatin immunoreactivity and its validation during recompensating therapy for CHF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[We describe the development of the first ELISA for myostatin immunoreactivity and its validation during recompensating therapy for CHF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP888410.RA7mHjDuWE5chFn7RP9-kaZiAoDXUkBRO-s3sc6mQBXR4130_assertion description "[We describe the development of the first ELISA for myostatin immunoreactivity and its validation during recompensating therapy for CHF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP888410.RA7mHjDuWE5chFn7RP9-kaZiAoDXUkBRO-s3sc6mQBXR4130_provenance.
- NP979879.RAd8uU5FifPt_MCyKq4JhgiWueoxvLtwmVnN32H6J1-_E130_assertion description "[We describe the development of the first ELISA for myostatin immunoreactivity and its validation during recompensating therapy for CHF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP979879.RAd8uU5FifPt_MCyKq4JhgiWueoxvLtwmVnN32H6J1-_E130_provenance.
- NP422112.RAyGIx1VGeRIoT3sIN_lNiw2RAeMhRJqzjquX67yFKK9Y130_assertion description "[We describe the development of the first ELISA for myostatin immunoreactivity and its validation during recompensating therapy for CHF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP422112.RAyGIx1VGeRIoT3sIN_lNiw2RAeMhRJqzjquX67yFKK9Y130_provenance.